O. Dhellin

发表

Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcription

T. Heidmann, J. Maestre, O. Dhellin, 1997, The EMBO journal.

Therapeutic Vaccination with TNF-Kinoid in TNF Antagonist-Resistant Rheumatoid Arthritis: A Phase II Randomized, Controlled Clinical Trial

X. Mariette, P. Miranda, P. Durez, 2014, PloS one.

IFN-gamma responses in peptide-treated melanoma patients measured by an ELISPOT assay using allogeneic dendritic cells.

S. Gabrielsson, C. Bonnerot, T. Dorval, 2004, Anticancer research.

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

Olivier Lantz, Laurence Zitvogel, Sebastian Amigorena, 2005, Journal of Translational Medicine.

Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus

J. Piette, M. Hoekman, Z. Amoura, 2011, Annals of the rheumatic diseases.

Protection from articular damage by passive or active anti‐tumour necrosis factor (TNF)‐α immunotherapy in human TNF‐α transgenic mice depends on anti‐TNF‐α antibody levels

J. Biton, E. Assier, O. Dhellin, 2013, Clinical and experimental immunology.

mRNA retroposition in human cells: processed pseudogene formation.

T. Heidmann, J. Maestre, O. Dhellin, 1995, The EMBO journal.

Retrotransposition of a marked Drosophila line-like I element in cells in culture.

L. Cavarec, T. Heidmann, S. Jensen, 1994, Nucleic acids research.

Safety, Immunogenicity and Clinical Phase I-II Results of TNFα-Kinoid Immunotherapeutic in Crohn's Disease Patients

G. Rogler, B. Fanget, F. Kruger, 2011 .

Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.

Eric Hachulla, Pierre Vandepapelière, Bernard Fanget, 2013, Arthritis and rheumatism.